Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2025 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| AG-RIVAROXABAN | angita pharma inc. | Marketed | Aug 22, 2024 | Marketed |
| AG-LETROZOLE TABLETS | angita pharma inc. | Marketed | Aug 20, 2024 | Marketed |
| JAMP LETROZOLE TABLETS | Jamp Pharma Corporation | Marketed | Aug 20, 2024 | Marketed |
| PENTA-V | CONSTANT INTERNATIONAL | Marketed | Aug 19, 2024 | Marketed |
| MEROPENEM FOR INJECTION | eugia pharma inc. | Marketed | Aug 19, 2024 | Marketed |
| QUILLIVANT ER ORAL SUSPENSION | kye pharmaceuticals inc. | Marketed | Aug 19, 2024 | Marketed |
| MEROPENEM FOR INJECTION | eugia pharma inc. | Marketed | Aug 19, 2024 | Marketed |
| AG-LATANOPROST | angita pharma inc. | Marketed | Aug 16, 2024 | Marketed |
| JAMP IPRATROPIUM HFA | Jamp Pharma Corporation | Marketed | Aug 15, 2024 | Marketed |
| CEFTRIAXONE FOR INJECTION | fresenius kabi canada ltd | Marketed | Aug 15, 2024 | Marketed |
| CEFTRIAXONE FOR INJECTION | fresenius kabi canada ltd | Marketed | Aug 15, 2024 | Marketed |
| AURO-DEFERASIROX (TYPE J) | auro pharma inc | Marketed | Aug 14, 2024 | Marketed |
| AURO-DEFERASIROX (TYPE J) | auro pharma inc | Marketed | Aug 14, 2024 | Marketed |
| AURO-DEFERASIROX (TYPE J) | auro pharma inc | Marketed | Aug 14, 2024 | Marketed |
| CORTOTIC | VIRBAC AH, INC. | Marketed | Aug 13, 2024 | Marketed |
| IRINOTECAN HYDROCHLORIDE INJECTION | eugia pharma inc. | Marketed | Aug 12, 2024 | Marketed |
| AG-DESVENLAFAXINE | angita pharma inc. | Marketed | Aug 12, 2024 | Marketed |
| MULTI-VITA CLEAR COAT BROAD SPECTRUM SPF 50 | murad llc | Marketed | Aug 12, 2024 | Marketed |
| SIBBORAN | trimedic therapeutics inc. | Marketed | Aug 11, 2024 | Marketed |
| LYSOL DISINFECTANT ADVANCED ALL PURPOSE CLEANER | RECKITT BENCKISER (CANADA) INC | Marketed | Aug 7, 2024 | Marketed |
